Showing results (151-160 of 900) with videos related to
Sort By:
Pageof 90
Clinical Lymphoma, Myeloma & Leukemia|September 25, 2021
SOHO State of the Art Updates & Next Questions: Intensive and Non-Intensive Approaches for Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaNicholas J Short, Hagop Kantarjian, Elias JabbourLeukemia & Lymphoma|June 8, 2024
Advances in the treatment of adults with newly diagnosed B-cell acute lymphoblastic leukemia: the role of frontline immunotherapy-based regimensNicholas J Short, Hagop Kantarjian, Elias JabbourLeukemia & Lymphoma|March 31, 2022
Hyperleukocytosis and leukostasis in acute and chronic leukemiasWalid Macaron, Zaven Sargsyan, Nicholas J ShortClinical Lymphoma, Myeloma & Leukemia|March 14, 2024
SOHO State of the Art Updates and Next Questions, Measurable Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaNicholas J Short, Elias Jabbour, Hagop KantarjianLeukemia|June 26, 2021
Optimizing the treatment of acute lymphoblastic leukemia in younger and older adults: new drugs and evolving paradigmsNicholas J Short, Hagop Kantarjian, Elias JabbourCurrent Hematologic Malignancy Reports|August 31, 2023
An Update on the Management of Advanced Phase Chronic Myeloid LeukemiaNicholas J Short, Jayastu Senapati, Elias JabbourAmerican Journal of Hematology|February 27, 2021
Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabineKiyomi Morita, Nitin Jain, Hagop Kantarjian, et al.Clinical Lymphoma, Myeloma & Leukemia|February 10, 2020
Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic LeukemiaGuillaume Richard-Carpentier, Elias Jabbour, Nicholas J Short, et al.Blood|October 25, 2023
Phase 2 study of inotuzumab ozogamicin for measurable residual disease in acute lymphoblastic leukemia in remissionElias Jabbour, Fadi G Haddad, Nicholas J Short, et al.Cancer Management and Research|October 22, 2019
Midostaurin In Acute Myeloid Leukemia: An Evidence-Based Review And Patient SelectionHussein A Abbas, Mansour Alfayez, Tapan Kadia, et al.Pageof 90